Donor and Allocation Considerations in Liver Transplantation
Nov
09
2025
Convention Center: Room 145, Level 1
2:00 PM
- 3:30 PM
Description
Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.Journey Maps
Presentations
2:00 PM
- 2:15 PM
Aug
06
2026
Convention Center - Room 145, Level 1
Replacing Creatinine with Cystatin C Enhances Mortality Prediction in All Modern Liver Allocation Scores
Giuseppe Cullaro, MD
, Abstract Presenter
Transplant
2:15 PM
- 2:30 PM
Aug
06
2026
Convention Center - Room 145, Level 1
Liver Viability Assessment during Normothermic Machine Perfusion and Normothermic Regional Perfusion using Indocyanine Green Clearance and Mitochondrial Biomarkers: A Prospective Study
Dilara Hatipoglu, MD
, Abstract Presenter
Transplant
2:30 PM
- 2:45 PM
Aug
06
2026
Convention Center - Room 145, Level 1
Impact of Acuity Circles Policy on ABO Blood Type-Related Waitlist Outcomes in Liver Transplantation
Dilara Hatipoglu, MD
, Abstract Presenter
Transplant
2:45 PM
- 3:00 PM
Aug
06
2026
Convention Center - Room 145, Level 1
Contemporary Patterns in Out of Sequence Allocation in Liver Transplantation
Dilara Hatipoglu, MD
, Abstract Presenter
Transplant
3:00 PM
- 3:15 PM
Aug
06
2026
Convention Center - Room 145, Level 1
Outcomes for Patients Listed for Liver Transplantation with Low MELD-Na Scores: High Frequency of Death, Removal from Waitlist and Liver Transplantation
Dilara Hatipoglu, MD
, Abstract Presenter
Transplant
3:15 PM
- 3:30 PM
Aug
06
2026
Convention Center - Room 145, Level 1
Risk Predictors for Recurrent and De Novo MASLD Post Liver Transplantation
Dilara Hatipoglu, MD
, Abstract Presenter
Transplant
Objectives
- Discuss recent findings related to donor and allocation considerations for liver transplant candidates.